Monoclonal Antibody Reduces Exacerbations In Asthmatics
Treatment of Symptoms of Asthma
Patients with symptomatic moderate asthma who were treated with anti-tumor necrosis factor alpha, an anti-inflammatory monoclonal antibody, experienced significantly fewer
Share this content.
If you liked this article and think it may help your friends, consider sharing or tweeting it to your followers.